G. Betts

发表

CD59 Blockade Enhances Antigen-Specific CD4+ T Cell Responses in Humans: A New Target for Cancer Immunotherapy?1

B. Morgan, A. Godkin, K. Gallagher, 2009, The Journal of Immunology.

CD4+CD25+FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer

Geraint T. Williams, J. Torkington, A. Godkin, 2006, PloS one.

CD4+CD25+FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer

Geraint T. Williams, J. Torkington, A. Godkin, 2006, PloS one.

Regulating the immune response to tumours.

H. Richards, A. Godkin, A. Gallimore, 2006, Advanced drug delivery reviews.

CD45RA Distinguishes CD4+CD25+CD127−/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression

P. Harden, K. Wood, K. Vogt, 2016, Transplantation.

Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer

Geraint T. Williams, P. Mizen, A. Godkin, 2011, Gut.

Assessing the Prognostic Value of Preoperative Carcinoembryonic Antigen-Specific T-Cell Responses in Colorectal Cancer

R. Hills, A. Godkin, A. Gallimore, 2015, Journal of the National Cancer Institute.

The impact of regulatory T cells on carcinogen-induced sarcogenesis

M. van den Broek, S. Sierro, A. Godkin, 2007, British Journal of Cancer.

Examination of serum miRNA levels in kidney transplant recipients with acute rejection.

P. Friend, K. Wood, S. Shankar, 2014, Transplantation.

Target for Cancer Immunotherapy? T Cell Responses in Humans: A New + CD4CD59 Blockade Enhances Antigen-Specific

B. Morgan, M. Gallagher, A. Gallimore, 2009 .

95 Inhibition of AKT signaling during expansion of TCR-engineered T-cells from patient leukocyte material generates SPEAR T-cells with enhanced functional potential in vitro

M. Dudley, J. Silk, K. Miller, 2020, Journal for ImmunoTherapy of Cancer.

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity

G. Screaton, A. Simon, H. Richards, 2007, European journal of immunology.

Reply: Forkhead box P3-positive regulatory T cells in immune surveillance and cancer

A. Godkin, A. Gallimore, G. Betts, 2007, British Journal of Cancer.

Evaluation of the Safety and Immunogenicity of a Candidate Tuberculosis Vaccine, MVA85A, Delivered by Aerosol to the Lungs of Macaques

H. McShane, M. Carroll, P. Marsh, 2013, Clinical and Vaccine Immunology.

by Aerosol to the Lungs of Macaques Tuberculosis Vaccine, MVA85A, Delivered Immunogenicity of a Candidate Evaluation of the Safety and

H. McShane, M. Carroll, Ann Williams, 2013 .

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma.

Daniel K. Wells, S. Grupp, W. Tap, 2018, Cancer discovery.

Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma

G. Demetri, S. Grupp, B. V. Van Tine, 2019, Journal of Immunotherapy for Cancer.

Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors.

K. Ladell, J. Dyson, Y. Singh, 2011, Cancer research.

379 Initial safety, efficacy, and product attributes from the SURPASS trial with ADP-A2M4CD8, a SPEAR T-cell therapy incorporating an affinity optimized TCR targeting MAGE-A4 and a CD8α co-receptor

D. Hong, P. Fracasso, S. Saibil, 2020 .

Optimising Immunogenicity with Viral Vectors: Mixing MVA and HAdV-5 Expressing the Mycobacterial Antigen Ag85A in a Single Injection

H. McShane, A. Hill, E. Stylianou, 2012, PloS one.

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A

H. McShane, E. Stylianou, L. Stockdale, 2015, Vaccine.

Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?

H. Thomas, R. Lechler, A. Godkin, 2008, The Journal of allergy and clinical immunology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Cholera Toxin Enhances Vaccine-Induced Protection against Mycobacterium Tuberculosis Challenge in Mice

H. McShane, H. Fletcher, E. Stylianou, 2013, PloS one.

Transiently Activated Human Regulatory T Cells Upregulate BCL-XL Expression and Acquire a Functional Advantage in vivo

R. Goto, K. Wood, J. Hester, 2019, Front. Immunol..

Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

F. Bushman, Melissa L. Johnson, B. V. Van Tine, 2023, Nature Medicine.

CD45RA distinguishes CD4+CD25+CD127-/low TSDR demethylated regulatory T cell subpopulations with differential stability and susceptibility to tacrolimus mediated inhibition of suppression.

P. Harden, K. Wood, K. Vogt, 2016, Transplantation.

Measurement of a 5-gene panel in whole blood in kidney transplant recipients with acute rejection and stable controls

P. Harden, P. Friend, K. Wood, 2015 .

Examination of serum miRNA levels in kidney transplant recipients with acute rejection.

P. Friend, K. Wood, S. Shankar, 2014, Transplantation.